ASX:AHC

Austco Healthcare Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive AHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Austco Healthcare and its competitors with MarketBeat's FREE daily newsletter.


About Austco Healthcare

Austco Healthcare Limited, together with its subsidiaries, provides communication and clinical workflow management solutions in Australia, New Zealand, Canada, the United Kingdom, the United States, Asia, and the Middle East. The company offers Tacera, an IP based nurse call system for hospitals, and aged care and acute care facilities. It also develops software. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was incorporated in 2004 and is based in Port Melbourne, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Austco Healthcare (ASX:AHC) Frequently Asked Questions

What stocks does MarketBeat like better than Austco Healthcare?

Wall Street analysts have given Austco Healthcare a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Austco Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Austco Healthcare's key executives?

Austco Healthcare's management team includes the following people:
  • Mr. Clayton Astles, CEO & Exec. Director
  • Mr. Brendan James Maher, CFO & Company Sec. (Age 53, Pay $399.22k)
  • Mr. Michael Read, Gen. Mang. of Australasia

Who are some of Austco Healthcare's key competitors?

What is Austco Healthcare's stock symbol?

Austco Healthcare trades on the ASX under the ticker symbol "AHC."

How much money does Austco Healthcare make?

Austco Healthcare has a market capitalization of $0.00 and generates $28.73 million in revenue each year.

How many employees does Austco Healthcare have?

Austco Healthcare employs 2,200 workers across the globe.

What is Austco Healthcare's official website?

The official website for Austco Healthcare is www.austcohealthcare.com.

How can I contact Austco Healthcare?

The company can be reached via phone at 61 3 9209 9688.


This page was last updated on 7/29/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.